Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Nahum Méndez-Sánchez, MD, PhD"'
Autor:
Genaro Vázquez-Elizondo, Guadalupe Ponciano-Rodríguez, Misael Uribe, Nahum Méndez-Sánchez, MD, PhD
Publikováno v:
Annals of Hepatology, Vol 8, Iss 1, Pp 32-37 (2009)
Background and aim: Primary biliary cirrhosis (PBC) is a chronic cholestatic disease of autoimmune origin and has a genetic component. Although it has been reported that the prevalence of the HLA-DRB1*08 allele is high in various populations, the pre
Externí odkaz:
https://doaj.org/article/03479d0199be42fb99bcc27b24a7b56b
Autor:
Raúl Carrillo-Esper, Daniela González-Avila, Marittza Uribe-Ríos, Nahum Méndez-Sánchez, MD, PhD.
Publikováno v:
Annals of Hepatology, Vol 7, Iss 1, Pp 87-90 (2008)
Since 2004, pegylated interferon (P-IFN) in combination with ribavirin has become the optimal choice of therapy for chronic hepatitis C virus (HCV) infection. IFN α-2b suppresses HCV replication and restores elevated serum aminotransferase levels, l
Externí odkaz:
https://doaj.org/article/20539f8c2ded43d4bd2577e300639242
Autor:
Nahum Méndez-Sánchez, MD, PhD, Claudia P. Sánchez-Castillo, Antonio R. Villa, Herlinda Madrigal, Beatriz Merino, Elsy García, Patricia López, Edgar Pichardo-Ontiveros, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 3, Iss 2, Pp 66-71 (2004)
Background & Aim: Liver cirrhosis continues to be an important cause of death in Mexico. Some data suggest that being overweight is a risk factor for chronic liver disease. The aim of this study was to assess the link between the incidences of being
Externí odkaz:
https://doaj.org/article/cb5db2aade5d4751a64e2c83378d6191
Autor:
Nahum Méndez-Sánchez, MD, PhD, Mariana Martínez, Verónica González, Ernesto Roldán-Valadez, MD, Miguel A Flores, MD, Misael Uribe, MD
Publikováno v:
Annals of Hepatology, Vol 1, Iss 1, Pp 40-43 (2002)
We have previously observed that UCB binds to ZnSO4in vitro, and suppresed the biliary bilirubin secretion in the hamster. The aim of this study was designed to investigate whether Zn salts might inhibit the enterohepatic cycling of UCB in subjects w
Externí odkaz:
https://doaj.org/article/bc4ee02e46a94e4689b92c16a676b676
Autor:
Nahum Méndez-Sánchez, MD, PhD, Daniel Motola-Kuba, MD, Jesús Bahena-Aponte, MD, Norberto Chavez-Tapia, MD, Raúl Pichardo-Bahena, MD, Misael Uribe, MD
Publikováno v:
Annals of Hepatology, Vol 2, Iss 4, Pp 183-185 (2003)
Nonalcoholic fatty liver disease (NAFLD) is a medical condition that may progress to end-stage liver disease. The spectrum of NAFLD is wide and ranges from simple fat accumulation in hepatocytes (steatosis), to fat accumulation plus necroinflammatory
Externí odkaz:
https://doaj.org/article/011fff33342249828ba495eead05d57b
Publikováno v:
Annals of Hepatology, Vol 9, Iss , Pp S7- (2010)
Externí odkaz:
https://doaj.org/article/439e99943f8e4472898e5565a51c52c1
Publikováno v:
Annals of Hepatology, Vol 4, Iss 1, Pp 3- (2005)
Externí odkaz:
https://doaj.org/article/87f530ff158c4200ae5c3c1c1e06bbbd
Publikováno v:
Annals of Hepatology, Vol 3, Iss 1, Pp 3- (2004)
Externí odkaz:
https://doaj.org/article/70d7b8b58b084cbd9124ac03fda60927
Publikováno v:
Annals of Hepatology, Vol 2, Iss 4, Pp 181- (2003)
Externí odkaz:
https://doaj.org/article/7960fba4cad043db92f0408d4a6cd4cf
Publikováno v:
Annals of Hepatology, Vol 2, Iss 2, Pp 98- (2003)
Externí odkaz:
https://doaj.org/article/11560dd55f1b445793b7db8291b295d7